N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
about
The identification of nitric oxide as endothelium-derived relaxing factorReciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implicationsS-nitrosothiols and the S-nitrosoproteome of the cardiovascular systemRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesN-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and miceNO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.Nitric oxide insufficiency and arterial thrombosis.Redox Pioneer: Professor Joseph Loscalzo.S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide.Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance.Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly.N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compoundsThe enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troublesDecreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis.Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives.Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.Local Delivery of an Ultra-short-acting Nitric Oxide-releasing Compound, DMHD/NO, Is Highly Effective in Inhibiting Acute Platelet-Thrombus Formation on Injured Arterial Strips.The vascular biology of S-nitrosothiols, nitrosated derivatives of thiols.New developments in nitrosovasodilator therapy.Glyceryl trinitrate and platelet aggregation: effects of N-acetyl-cysteine.Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cellsHuman vascular smooth muscle cells inhibit platelet aggregation when incubated with glyceryl trinitrate: evidence for generation of nitric oxide.S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.Time-dependent inhibition by glyceryl trinitrate of platelet aggregation caused by U46619 (a thromboxane/endoperoxide receptor agonist).Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in man.Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species.The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.High dose intracoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction.
P2860
Q26823143-35DF0AFF-D824-4CA5-AF5F-AC4942E9831BQ26852195-ACEEFD3F-B340-43F9-93BC-FF9638CE8A65Q26852676-FD48C849-FD88-49E9-8584-E9A31569E475Q27021421-750CED02-E5E5-4661-B8CA-75C9851389FFQ30497987-891FC0CF-54D3-4DB8-B541-65E7897B72D1Q33896104-D099E832-7DBA-4DE7-9650-CDFC177117EFQ33958696-325C425C-D547-4878-899B-016B7A76B5A5Q34222592-198B30BE-9180-4FF6-9CEF-B83575423702Q35756888-9DD07CA9-61ED-4E6F-8145-F4C6E29C4B1CQ35767797-F238DBE9-DC64-4C9C-8356-624ACC21B243Q35826948-FAC181AF-742C-43F1-9392-AA93A3A14CF2Q36077331-73FDDB5A-81E7-49B6-A16E-8325774F5A80Q36277926-D4D4EC02-AB7E-4109-8BA6-4D51A1341D20Q36780079-4BA38781-716A-4AB0-905D-F30A909DAFD4Q37198569-B84F3B15-5E07-4009-8E8C-EE2E0D015512Q37352044-A436C706-F797-4727-9C2A-C49D016664C1Q37963774-88CF87C1-578F-4F01-A1DC-920B7A7F5CD3Q39765589-90CF4C44-D1F8-4460-9311-52BBF69123DCQ41720842-756BA947-9E48-43C1-923B-A8FCF5E4ACADQ41740334-43F9B950-E6AB-4250-A776-3961214C06A6Q41740454-AAAB76D9-AE9B-48EF-AEAF-44EFE9366835Q42117808-A50C616F-91D3-4A38-92AC-CE603E47AD32Q42507388-E5D25611-BE93-441E-91F3-06438A3E7C44Q42560973-197ABD39-86C0-408C-BFBF-59258F8AD31EQ42600997-4864AA1C-8FD4-4BE9-901E-17F42B37A53BQ42920544-929F77C7-7436-4B35-8AA4-F0F4013F1340Q43201684-95412372-7F00-4D23-9CBD-8931F770C100Q43222811-27FDA401-61ED-44EF-B949-51C18A7AFD50Q43882919-8B400836-0FBA-4470-BBD2-45701E513DF9Q47667272-6116EDDB-F549-49A6-9189-22F7E4617AB4Q54448636-2B1D9DE0-BB9A-4BF7-BEA2-D056307F23B6
P2860
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@ast
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@en
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@nl
type
label
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@ast
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@en
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@nl
prefLabel
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@ast
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@en
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@nl
P2860
P356
P1476
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
@en
P2093
J Loscalzo
P2860
P304
P356
10.1172/JCI112024
P407
P577
1985-08-01T00:00:00Z